Correlation Between Protagenic Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Protagenic Therapeutics and Eliem Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Protagenic and Eliem is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 5.15 times less return on investment than Eliem Therapeutics. In addition to that, Protagenic Therapeutics is 1.01 times more volatile than Eliem Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 257.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would earn a total of 43.00 from holding Eliem Therapeutics or generate 16.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagenic Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Protagenic Therapeutics |
| Eliem Therapeutics |
Protagenic Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagenic Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Protagenic Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |